Latest Regulatory News

South Harz Potash has identified a new copper-gold mineralised zone at its Glava Project in Sweden, highlighted by impressive assays including 9.88g/t gold and 2.88% copper, alongside significant rare earth element mineralisation. The findings validate historical data and set the stage for a maiden drill program planned for mid-2026.

American Uranium's recent hydrogeological pump tests at the Lo Herma project validate key aquifer properties consistent with nearby operating ISR uranium mines, supporting upcoming resource and scoping study updates.

BHP has reported a robust operational half-year, setting new production records and raising its copper output forecast for FY26 amid strong commodity prices.

VBX Limited reports a significant 51% increase in the Measured and Indicated Mineral Resource Estimate for its Wuudagu B and C plateaus, setting the stage for a longer mine life and enhanced project economics.

HUB24 has reported record net inflows of $5.6 billion in Q2 FY26, pushing total funds under administration to $152.3 billion and expanding its market share to 9.3%. The company also unveiled a new lifetime retirement solution and an AI-driven adviser ecosystem.

Telix Pharmaceuticals has achieved a key milestone with China’s NMPA accepting its New Drug Application for Illuccix, a prostate cancer imaging agent backed by strong Phase 3 data. This paves the way for Telix to enter a rapidly growing Chinese market alongside its global approvals.

Hot Chili Limited reports significant diamond drilling results at its La Verde copper-gold project in Chile, revealing extensive high-grade mineralisation from near surface and extending previous intercepts. These findings bolster the strategic value of the Costa Fuego project amid rising copper and gold prices.

VRX Silica Limited has locked in six binding offtake contracts totaling nearly 1 million tonnes per annum and appointed a new CEO, marking significant progress for its Arrowsmith North silica sand project.

Tungsten Mining NL advances its Mt Mulgine project with a robust scoping study, revealing a globally significant multi-critical mineral deposit poised to meet soaring tungsten demand amid supply constraints.

Cambium Bio has locked in a A$2.4 million strategic investment from Zheng Yang Biomedical Technology, reinforcing its push into pivotal Phase 3 trials for its dry eye disease treatment.

Fletcher Building has agreed to sell its Construction Division to global giant VINCI Construction for an initial $315.6 million, with potential to rise to $334.1 million. The move marks a strategic pivot towards focused building products manufacturing.

Identitii Limited has voluntarily suspended trading of its deferred settlement securities following a takeover dispute initiated by Mitchell Asset Management. The suspension awaits a critical announcement on the Takeovers Panel's decision.